Long-term safety of an early ACE-inhibitor treatment of patients with acute myocardial infarction: Results of the 3 year follow-up period on 696 Swiss patients randomized to the ISIS-4 trial

Zeitschrift fur Kardiologie

Volumn 89, Issue 2, 2000, Pages 81-83

  Genoni, M ^a   Malacrida, R ^a   Sessa, F ^a   Siegrist, P ^a   Maggioni, A P ^b   Moccetti, T ^a  

^a Ospedale Civico Lugano   (Switzerland)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

ACE inhibitors; Acute myocardial infarction; Prognosis

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK BENEFIT ANALYSIS; SWITZERLAND; TREATMENT OUTCOME;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; RECURRENCE; SURVIVAL ANALYSIS; SWITZERLAND;

EID: 0034020714     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920050013     Document Type: Article

References (11)

1. 1. Swedberg K, Held P, Kjekshus J, Rasmussen K, Rydén L, Wedel H, Consensus II Study Group (1992) Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. N Engl J Med 327:678-84
2. 2. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (1994) GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 343:1115-22
3. 3. ISIS-4 Collaborative Group (1995) ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 345:669-685
4. 4. Chinese Cardiac Study Collaborative Group (1995) Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1). Lancet 345:686-87
5. 5. Ambrosioni E, Borghi C, Magnani B, for the Survival of Myocardial Infarction Long-term Evaluation (SMILE) Study Investigators (1995) The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 332:80-5
6. 6. White HH, van de Werf FJJ (1998) Thrombolysis for acute myocardial infarction. Circulation 97:1632-46
7. 7. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Six-month effects of early treatment with Lisinopril and Transdermal Glyceryl Trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial. J Am Coll Cardiol 27: 337-44
8. 8. Latini R, Maggioni AP, Flather M, Sleight P, Tognoni G, et al (1995) ACE-inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials. Circulation 92:3132-3137
9. 9. Ofeffer MA, Brauwald E, Moyö LA (SAVE) (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial (SAVE). New Engl J Med 327:669-677
10. 10. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators: Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342:821-828
11. 11. Torp-Pedersen C, Kober L, Carlson J (1995) Angiotensin-converting enzyme inhibition after myocardial infarction: The Trandolapril Cardiac Evaluation study. Am Heart J 132:235-243